350 related articles for article (PubMed ID: 24948876)
1. Conversion of androgen receptor signaling from a growth suppressor in normal prostate epithelial cells to an oncogene in prostate cancer cells involves a gain of function in c-Myc regulation.
Vander Griend DJ; Litvinov IV; Isaacs JT
Int J Biol Sci; 2014; 10(6):627-42. PubMed ID: 24948876
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/TCF-4 complex inhibition of c-MYC transcription.
Antony L; van der Schoor F; Dalrymple SL; Isaacs JT
Prostate; 2014 Aug; 74(11):1118-31. PubMed ID: 24913829
[TBL] [Abstract][Full Text] [Related]
3. Resolving the Coffey Paradox: what does the androgen receptor do in normal vs. malignant prostate epithelial cells?
Isaacs JT
Am J Clin Exp Urol; 2018; 6(2):55-61. PubMed ID: 29666833
[TBL] [Abstract][Full Text] [Related]
4. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
Dulinska-Litewka J; McCubrey JA; Laidler P
Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
[TBL] [Abstract][Full Text] [Related]
5. NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer.
Yu C; Wu G; Li R; Gao L; Yang F; Zhao Y; Zhang J; Zhang R; Zhang J; Yao L; Yuan J; Li X
Cancer Biol Ther; 2015; 16(2):287-96. PubMed ID: 25756511
[TBL] [Abstract][Full Text] [Related]
6. Androgen induces differentiation of a human papillomavirus 16 E6/E7 immortalized prostate epithelial cell line.
Ling MT; Chan KW; Choo CK
J Endocrinol; 2001 Jul; 170(1):287-96. PubMed ID: 11431162
[TBL] [Abstract][Full Text] [Related]
7. MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity.
Whitlock NC; Trostel SY; Wilkinson S; Terrigino NT; Hennigan ST; Lake R; Carrabba NV; Atway R; Walton ED; Gryder BE; Capaldo BJ; Ye H; Sowalsky AG
Oncogene; 2020 Aug; 39(34):5663-5674. PubMed ID: 32681068
[TBL] [Abstract][Full Text] [Related]
8. c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks.
Barfeld SJ; Urbanucci A; Itkonen HM; Fazli L; Hicks JL; Thiede B; Rennie PS; Yegnasubramanian S; DeMarzo AM; Mills IG
EBioMedicine; 2017 Apr; 18():83-93. PubMed ID: 28412251
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor differentially regulates the proliferation of prostatic epithelial cells in vitro and in vivo.
Yang S; Jiang M; Grabowska MM; Li J; Connelly ZM; Zhang J; Hayward SW; Cates JM; Han G; Yu X
Oncotarget; 2016 Oct; 7(43):70404-70419. PubMed ID: 27611945
[TBL] [Abstract][Full Text] [Related]
10. Multiple androgen response elements and a Myc consensus site in the androgen receptor (AR) coding region are involved in androgen-mediated up-regulation of AR messenger RNA.
Grad JM; Dai JL; Wu S; Burnstein KL
Mol Endocrinol; 1999 Nov; 13(11):1896-911. PubMed ID: 10551783
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells.
Nadiminty N; Tummala R; Lou W; Zhu Y; Zhang J; Chen X; eVere White RW; Kung HJ; Evans CP; Gao AC
J Biol Chem; 2012 Jan; 287(2):1527-37. PubMed ID: 22128178
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor dampens tissue factor expression via nuclear factor-κB and early growth response protein 1.
Hoesel B; Mussbacher M; Dikorman B; Salzmann M; Assinger A; Hell L; Thaler J; Basílio J; Moser B; Resch U; Paar H; Mackman N; Schmid JA
J Thromb Haemost; 2018 Apr; 16(4):749-758. PubMed ID: 29427323
[TBL] [Abstract][Full Text] [Related]
13. Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells.
Kim YC; Chen C; Bolton EC
PLoS One; 2015; 10(9):e0138286. PubMed ID: 26372468
[TBL] [Abstract][Full Text] [Related]
14. Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.
Chuu CP; Kokontis JM; Hiipakka RA; Fukuchi J; Lin HP; Lin CY; Huo C; Su LC; Liao S
Cancer Sci; 2011 Nov; 102(11):2022-8. PubMed ID: 21781227
[TBL] [Abstract][Full Text] [Related]
15. Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex.
Nyquist MD; Coleman IM; Lucas JM; Li D; Hanratty B; Meade H; Mostaghel EA; Plymate SR; Corey E; Haffner MC; Nelson PS
Cancer Res; 2023 Sep; 83(17):2938-2951. PubMed ID: 37352376
[TBL] [Abstract][Full Text] [Related]
16. Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes.
Olsen JR; Azeem W; Hellem MR; Marvyin K; Hua Y; Qu Y; Li L; Lin B; Ke X; Øyan AM; Kalland K
BMC Cancer; 2016 Jul; 16():377. PubMed ID: 27378372
[TBL] [Abstract][Full Text] [Related]
17. DNA licensing as a novel androgen receptor mediated therapeutic target for prostate cancer.
D'Antonio JM; Vander Griend DJ; Isaacs JT
Endocr Relat Cancer; 2009 Jun; 16(2):325-32. PubMed ID: 19240183
[TBL] [Abstract][Full Text] [Related]
18. A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells.
Hessenkemper W; Roediger J; Bartsch S; Houtsmuller AB; van Royen ME; Petersen I; Grimm MO; Baniahmad A
Mol Endocrinol; 2014 Nov; 28(11):1831-40. PubMed ID: 25203674
[TBL] [Abstract][Full Text] [Related]
19. Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells.
Vander Griend DJ; D'Antonio J; Gurel B; Antony L; Demarzo AM; Isaacs JT
Prostate; 2010 Jan; 70(1):90-9. PubMed ID: 19790235
[TBL] [Abstract][Full Text] [Related]
20. Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling.
D'Antonio JM; Vander Griend DJ; Antony L; Ndikuyeze G; Dalrymple SL; Koochekpour S; Isaacs JT
PLoS One; 2010 Jul; 5(7):e11475. PubMed ID: 20628607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
